**Core Concept**
Metaiodobenzylguanidine (MIBG) is a radiopharmaceutical that accumulates in cells with high sympathetic nervous system activity, particularly those derived from the neural crest. MIBG is taken up by cells with a high density of norepinephrine transporters, which are expressed in neuroendocrine cells.

**Why the Correct Answer is Right**
MIBG is selectively taken up by neuroendocrine cells, such as those found in pheochromocytomas, paragangliomas, and neuroblastomas. In these cells, MIBG is then trapped through a non-specific mechanism, allowing for imaging and localization of these tumors. The high sensitivity of MIBG scans makes them particularly useful for detecting and monitoring neuroendocrine tumors.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because MIBG is not specifically concentrated in catecholamine-producing tumor cells. While MIBG does accumulate in these cells, it is the norepinephrine transporters that are responsible for MIBG uptake, not the production of catecholamines.
* **Option B:** While MIBG scans can be used in pheochromocytoma, option C is a more specific and accurate statement regarding the primary use of MIBG scans.
* **Option D:** MIBG scans can be used in paraganglioma, but option C is a more common and well-established application of MIBG scans.
* **Option E:** Carcinoids are neuroendocrine tumors, but MIBG scans are not typically used for their detection or management.

**Clinical Pearl / High-Yield Fact**
MIBG scans are particularly useful for detecting and monitoring neuroblastomas, which are the most common extracranial solid tumors in children.

**Correct Answer:** C. Used in Neuroblastoma